Screener
Neuropace, Inc. NPCE Total Liabilities
Total Liabilities at other companies
Other financials
Where this comes from
Reported directly by Neuropace, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesFairValueDisclosure.
The source filing: Neuropace, Inc.’s 10-Q, filed August 11, 2026. Open the filing →
- Filed
- Aug 11, 2026, 4:33 PM EDT
- Fiscal quarter
- Q4 FY2030
- Calendar quarter
- Q4 2030
- Accession
- 0001528287-26-000030
FAQ
- What is Neuropace, Inc.'s total liabilities?
- Neuropace, Inc. (NPCE) reported total liabilities of $0 in Q2 2026.
- What is the long-term trend for Neuropace, Inc.'s total liabilities?
- Over 5 years (2020 to 2025), Neuropace, Inc.'s total liabilities has grown at a -100.0% compound annual growth rate (CAGR), from $369K to $0.
- What does total liabilities mean?
- The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.
Ask your AI about Neuropace, Inc.'s total liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude